Primary Immunodeficiency Disease
10 clinical trials · Condition
◉ Watch Primary Immunodeficiency Disease
| Record | Firm | Date |
|---|---|---|
| An Extension Study of TAK-664 for Japanese People With Primary Immunodeficiency Disease (NCT04842643) | Takeda | 2021-04-27 |
| Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10) (NCT04944979) | Kedrion S.p.A. | 2021-03-31 |
| Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID Patients (NCT03961009) | Kedrion S.p.A. | 2019-04-30 |
| Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment (NCT03677557) | Ottawa Hospital Research Institute | 2018-09-19 |
| Pediatric Primary Immunodeficiency Disease (PID) in China (NCT03252548) | Beijing Children's Hospital | 2018-01-01 |
| High Infusion Rate Study of Immunoglobulin Intravenous (Human) 10% (NewGam) (NCT01313507) | Octapharma | 2011-05-01 |
| Clinical and Laboratory Online Patient- and Research Database for Primary Immunodeficiencies in Switzerland (NCT01150240) | University of Zurich | 2006-10-01 |
Track Primary Immunodeficiency Disease automatically
Every clearance here is in the API, with alerts when new ones post.